ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H (HK:1541) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. has announced the composition of its Board of Directors, including Executive, Non-executive, and Independent Non-executive members. The company also disclosed the structure of its three Board committees—Audit, Remuneration, and Nomination—detailing the roles of each director with specific committee chairmanships and memberships.
For further insights into HK:1541 stock, check out TipRanks’ Stock Analysis page.